Yahoo Web Search

Search results

  1. May 6, 2021 · In U.S. hospitals during January–March 2021, receipt of Pfizer-BioNTech or Moderna COVID-19 vaccines was 94% effective against COVID-19 hospitalization among fully vaccinated adults and 64% effective among partially vaccinated adults aged ≥65 years.

    • Mark W. Tenforde, Samantha M. Olson, Wesley H. Self, H. Keipp Talbot, Christopher J. Lindsell, Jay S...
    • 2021
  2. Pfizer-BioNTech COVID-19 Vaccine At-A-Glance Guidance below summarizes basic storage, preparation, scheduling, administration, and dosage for all 2023–24 Pfizer-BioNTech COVID-19 Vaccine products. Distributed in: Ages: 6 months through 4 years Multiple-dose vial: yellow cap and yellow label Ages: 5 through 11 years Single dose vial:

  3. Sep 23, 2021 · Among U.S. adults without immunocompromising conditions, vaccine effectiveness against COVID-19 hospitalization during March 11–August 15, 2021, was higher for the Moderna vaccine (93%) than the Pfizer-BioNTech vaccine (88%) and the Janssen vaccine (71%).

    • Wesley H. Self, Mark W. Tenforde, Jillian P. Rhoads, Manjusha Gaglani, Manjusha Gaglani, Adit A. Gin...
    • 2021
  4. Jul 25, 2024 · A 2021 study examined the effectiveness of two mRNA vaccine doses in immunocompromised people. It found that the Pfizer vaccine was 71% effective, and the Moderna vaccine was 81% effective.

  5. Fact Sheet for the authorized Pfizer-BioNTech COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, and also includes information about the U.S. Food and Drug Administration (FDA)-licensed vaccine,

  6. May 5, 2021 · In a multistate network of U.S. hospitals during January–March 2021, receipt of Pfizer-BioNTech or Moderna COVID-19 vaccines was 94% effective against COVID-19 hospitalization among fully vaccinated adults and 64% effective among partially vaccinated adults aged ≥65 years.

  7. May 1, 2024 · In December 2020, the Pfizer-BioNTech COVID-19 vaccine two-dose series was found to be both safe and effective in preventing COVID-19 infection in people age 18 and older. This data helped predict how well the vaccines would work for younger people.

  1. People also search for